FDA Inspection
ARUP Laboratories, Inc.ARUP Laboratories, Inc. – FDA Inspection, Jul 14, 2017
Record Details
This FDA Inspection record concerns ARUP Laboratories, Inc., with an inspection on July 14, 2017, issued by the Denver District Office, covering human drugs.
- Office
- Denver District Office
- Person
- Srinivas Chennamaneni (Issuing Officer)
View Company Profile
ID · ffb9e5eb-304c-495c-b633-05064b2e0e9c
Inspection Facts
- Inspection number
- 1036656
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of ARUP Laboratories, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 17, 2025 | OAI | Denver District Office | Product Evaluation: Medical Devices |
| December 4, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 11, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 18, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 30, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ARUP Laboratories, Inc.
- FDA Inspection 1295758 - 2025-12-17
- FDA Inspection 1294066 - 2025-12-04
- FDA Inspection 1086864 - 2019-03-11
- FDA Inspection 998801 - 2016-11-18
- FDA Inspection 911879 - 2015-01-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.